A simple risk stratification for time to development of sight-threatening diabetic retinopathy

Diabetes Care

Volumn 36, Issue 3, 2013, Pages 580-585

  Stratton, Irene M ^a   Aldington, Stephen J ^a   Taylor, David J ^b   Adler, Amanda I ^c   Scanlon, Peter H ^a  

^a CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE SEVERITY; EYE PHOTOGRAPHY; FEMALE; HEALTH PROGRAM; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH SERVICE; POPULATION RESEARCH; RISK ASSESSMENT; SIGHT THREATENING DIABETIC RETINOPATHY; UNITED KINGDOM; VISUAL SYSTEM EXAMINATION;

AGED; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PHOTOGRAPHY; RISK FACTORS;

EID: 84874406781     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0625     Document Type: Article

References (21)

1. Diabetic Retinopathy ADA. Diabetes Care 2002;25(Suppl. 1):s90-s93
2. Scanlon PH. The English national screening programme for sight-threatening diabetic retinopathy. J Med Screen 2008;15:1-4
3. Wong TY, Mwamburi M, Klein R, et al. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care 2009;32:2307-2313
4. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008;115:1859-1868
5. JamesM, Turner DA, Broadbent DM, Vora J, Harding SP. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ 2000;320:1627-1631
6. Vijan S, Hofer TP, Hayward RA. Costutility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA 2000;283:889-896
7. Department of Health. Integrated Perfomance Measures Monitoring [Internet], 2011. Available at http://www.dh.gov.uk/en/ Publicationsandstatistics/Statistics/Performancedataandstatistics/ Integratedperfomancemeasuresmonitoring/index. htm. Accessed 3 May 2012
8. International Diabetes Federation. One adult in ten will have diabetes by 2030 [Internet], 2011. Available at http://www.idf.org/media-events/press- releases/2011/diabetes-atlas-5th-edition. Accessed 27 August 2012
9. Kempen JH, O'Colmain BJ, Leske MC, et al.; Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004;122:552-563
10. Younis N, Broadbent DM, Harding SP, Vora JP. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme. Diabet Med 2003;20:758-765
11. Younis N, Broadbent DM, Vora JP, Harding SP; Liverpool Diabetic Eye Study. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003;361:195-200
12. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998; 105:1801-1815
13. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care 1998; 21:143-156
14. Mehlsen J, ErlandsenM, Poulsen PL, Bek T. Individualized optimization of the screening interval for diabetic retinopathy: a new model. Acta Ophthalmol 2012;90:109-114
15. Scanlon PH, Carter SC, Foy C, Husband RF, Abbas J, Bachmann MO. Diabetic retinopathy and socioeconomic deprivation in Gloucestershire. J Med Screen 2008;15:118-121
16. Harding S, Greenwood R, Aldington S, et al.; Diabetic Retinopathy Grading and Disease Management Working Party. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 2003; 20:965-971
17. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 1991;98(Suppl.): 823-833
18. Vijan S, Hofer TP, Hayward RA. How often should patients be screened for retinopathy. Reply to letter to the Editor. JAMA 2000; 284:437-439.
19. Zoega GM, Gunnarsdóttir T, Björnsdóttir S, Hreietharsson AB, Viggósson G, Stef-ansson E. Screening compliance and visual outcome in diabetes. Acta Ophthalmol Scand 2005;83:687-690
20. National Health Service. Excluding Patients fromtheNHSDiabetic Retinopathy Screening Programme Temporarily or Permanently: Good Practice Guide [Internet], 2006. Available at http://diabeticeye. screening.nhs.uk/. Accessed 3 May 2012
21. Thomas RL, Dunstan F, Luzio SD, et al. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service forWales: retrospective analysis. BMJ 2012;344:e874